C3.ai, Inc.
C3.ai, Inc. operates as an enterprise artificial intelligence application software company. The company offers C3 agentic AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI CRM Suite, a customer relationship management solution; C3 Generative AI that enables to locate, retrieve, present information, disparate data stores, applications, and enterprise information systems; C3 AI Health Suite to accelerate healthcare innovation; and C3 AI Financial Services Suite. Its C3 AI Applications include C3 AI Asset Performance suite, which consists of C3 AI Reliability, C3 AI Process Optimization, and C3 AI Energy Management applications. The company's C3 AI Supply Chain Suite comprises C3 AI Supply Network Risk, C3 AI Inventory Optimization, C3 AI Demand Forecasting, C3 AI Production Schedule Optimization, and C3 AI Sourcing Optimization solutions; C3 AI Sustainability Suite includes C3 AI ESG and C3 AI Energy Management applications to decrease greenhouse gas emissions; and C3 AI Defense & Intelligence Suite. It provides C3 AI State and Local Government Suite that includes various applications, such as C3 Law Enforcement for state, county, and municipal law enforcement agencies; C3 AI Residential Property Appraisal and C3 AI Commercial Property Appraisal for county property assessors and appraisers; and C3 Generative AI for Government Programs and C3 Generative AI for Constituent Services for federal, state, and local governments. It has strategic partnerships with Microsoft Azure, AWS, Google Cloud, McKinsey & Company, Baker Hughes, Booz Allen, and others. The company has a strategic alliance with SMX Group, LLC for the development of mission critical AI in the secure environments. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.
Open AI dashboard ↗IQVIA Holdings Inc.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
Open IQV dashboard ↗